Comment in

• Pharmaceutical industry is invited to respond to amnesty for unreported trials.

  Roberts I. Roberts I. BMJ. 1997 Sep 13;315(7109):683. doi: 10.1136/bmj.315.7109.683b. BMJ. 1997. PMID: 9310592 Free PMC article. No abstract available.
• Regulating the pharmaceutical industry. General public does not support value system inherent in cost effectiveness analyses.

  Furniss J, Zammit-Lucia J, Johnson N. Furniss J, et al. BMJ. 1998 Jan 17;316(7126):226; author reply 228. BMJ. 1998. PMID: 9468699 Free PMC article. No abstract available.
• Regulating the pharmaceutical industry. Authors seem to have misunderstood pharmaceutical price regulation scheme.

  Read P. Read P. BMJ. 1998 Jan 17;316(7126):226; author reply 228. BMJ. 1998. PMID: 9468700 Free PMC article. No abstract available.
• Regulating the pharmaceutical industry. Having rationing rules for new pharmaceuticals but not other treatments is senseless.

  Towse A. Towse A. BMJ. 1998 Jan 17;316(7126):227. BMJ. 1998. PMID: 9468701 Free PMC article. No abstract available.
• Regulating the pharmaceutical industry. Regulation may no longer be necessary.

  Rowlatt P. Rowlatt P. BMJ. 1998 Jan 17;316(7126):227; author reply 228. BMJ. 1998. PMID: 9468702 Free PMC article. No abstract available.
• Regulating the pharmaceutical industry. Australian scheme has disadvantages.

  Clear PR, Grobler M. Clear PR, et al. BMJ. 1998 Jan 17;316(7126):227. BMJ. 1998. PMID: 9468703 Free PMC article. No abstract available.
• Regulating the pharmaceutical industry. Further controls would discourage companies from investing in research.

  Lance SP. Lance SP. BMJ. 1998 Jan 17;316(7126):227-8; author reply 228. BMJ. 1998. PMID: 9468704 Free PMC article. No abstract available.